In the era of Explainable Artificial Intelligence, there is a renewed focus on single trees for their ease of interpretation. This paper introduces Simultaneous Latent Budget Trees, a probabilistic machine learning framework for classification trees in the presence of a stratification factor such as a temporal, spatial, or demographic variable, acting as a control variable or potential confounder. Standard tree growth procedures are not designed to optimize a conditional split rule. A model-based split rule is proposed in which child nodes are interpreted as latent components of a simultaneous mixture model, such as the Simultaneous Latent Budget Model and its constrained versions, fitted to the parent node. Mixing parameters drive the observations, differently for each group, to the child nodes whereas latent budgets parameters update the response classes profile of each level of the control variable. Parameters are estimated by least squares considering a neural network perspective of the model. An informative tree structure can be interactively visualized with interpretation aids on the node and the paths, including visual pruning and decision tree selection procedure. Suitable measures are proposed to handle an unbalanced response class distribution. The proposed methodology is applied to investigate gender-related differences in disease progression of Amyotrophic Lateral Sclerosis. The SLBT library with the various tree-based algorithms is available in the linked GitHub repository.

Understanding how biomarker distributions evolve over time is a central challenge in digital health and chronic disease monitoring. In diabetes, changes in the distribution of glucose measurements can reveal patterns of disease progression and treatment response that conventional summary measures miss. Motivated by a 26-week clinical trial comparing the closed-loop insulin delivery system t:slim X2 with standard therapy in children with type 1 diabetes, we propose a probabilistic framework to model the continuous-time evolution of time-indexed distributions using continuous glucose monitoring data (CGM) collected every five minutes. We represent the glucose distribution as a Gaussian mixture, with time-varying mixture weights governed by a neural ODE. We estimate the model parameter using a distribution-matching criterion based on the maximum mean discrepancy. The resulting framework is interpretable, computationally efficient, and sensitive to subtle temporal distributional changes. Applied to CGM trial data, the method detects treatment-related improvements in glucose dynamics that are difficult to capture with traditional analytical approaches.

Medical researchers are coming to appreciate that many diseases are in fact complex, heterogeneous syndromes composed of subpopulations that express different variants of a related complication. Longitudinal data extracted from individual electronic health records (EHR) offer an exciting new way to study subtle differences in the way these diseases progress over time. In this paper, we focus on answering two questions that can be asked using these databases of longitudinal EHR data. First, we want to understand whether there are individuals with similar disease trajectories and whether there are a small number of degrees of freedom that account for differences in trajectories across the population. Second, we want to understand how important clinical outcomes are associated with disease trajectories. To answer these questions, we propose the Disease Trajectory Map (DTM), a novel probabilistic model that learns low-dimensional representations of sparse and irregularly sampled longitudinal data. We propose a stochastic variational inference algorithm for learning the DTM that allows the model to scale to large modern medical datasets. To demonstrate the DTM, we analyze data collected on patients with the complex autoimmune disease, scleroderma. We find that DTM learns meaningful representations of disease trajectories and that the representations are significantly associated with important clinical outcomes.

Nanopore sequencing is the third-generation sequencing technology with capabilities of generating long-read sequences and directly measuring modifications on DNA/RNA molecules, which makes it ideal for biological applications such as human Telomere-to-Telomere (T2T) genome assembly, Ebola virus surveillance and COVID-19 mRNA vaccine development. However, accuracies of computational methods in various tasks of Nanopore sequencing data analysis are far from satisfactory. For instance, the base calling accuracy of Nanopore RNA sequencing is $\sim$90\%, while the aim is $\sim$99.9\%. This highlights an urgent need of contributions from the machine learning community. A bottleneck that prevents machine learning researchers from entering this field is the lack of a large integrated benchmark dataset.

While synthetic data hold great promise for privacy protection, their statistical analysis poses significant challenges that necessitate innovative solutions. The use of deep generative models (DGMs) for synthetic data generation is known to induce considerable bias and imprecision into synthetic data analyses, compromising their inferential utility as opposed to original data analyses. This bias and uncertainty can be substantial enough to impede statistical convergence rates, even in seemingly straightforward analyses like mean calculation.

Data analysis is a crucial analytical process essential for deriving insights from real-world databases.

However, differential privacy's worst-case nature entails scaling such noise to the range of the queries even for

However,in manyapplications there are several different parameters one might wish to vary: for example, scale and density. In contrast to the one-parameter setting, techniques for applying statistics and machine learning in the setting of multiparameter persistence are not well understood due to the lack of a concise representationoftheresults.